L2T1 Stock Overview
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
LifeVantage Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.70 |
| 52 Week High | US$7.70 |
| 52 Week Low | US$2.78 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | 8.57% |
| 1 Year Change | 92.57% |
| 3 Year Change | -18.57% |
| 5 Year Change | -42.91% |
| Change since IPO | -54.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| L2T1 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -6.6% | 4.3% | 0.5% |
| 1Y | 92.6% | -2.3% | 1.3% |
Return vs Industry: L2T1 exceeded the German Personal Products industry which returned -2% over the past year.
Return vs Market: L2T1 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| L2T1 volatility | |
|---|---|
| L2T1 Average Weekly Movement | 7.4% |
| Personal Products Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L2T1 has not had significant price volatility in the past 3 months.
Volatility Over Time: L2T1's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 248 | Steve Fife | www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name.
LifeVantage Corporation Fundamentals Summary
| L2T1 fundamental statistics | |
|---|---|
| Market cap | €74.02m |
| Earnings (TTM) | €2.76m |
| Revenue (TTM) | €196.65m |
27.1x
P/E Ratio0.4x
P/S RatioIs L2T1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L2T1 income statement (TTM) | |
|---|---|
| Revenue | US$210.95m |
| Cost of Revenue | US$42.93m |
| Gross Profit | US$168.02m |
| Other Expenses | US$165.06m |
| Earnings | US$2.96m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 79.65% |
| Net Profit Margin | 1.40% |
| Debt/Equity Ratio | 0% |
How did L2T1 perform over the long term?
See historical performance and comparison